7 Список литературы

1. Selzer A. Changing aspects of the natural history of valvular aortic stenosis.N Engl J Med 1987; 317:91- 8.

2. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol 1993; 24:13308.

3. Stephan PJ, Henry AC III, Hebeler RF Jr, Whiddon L, Roberts WC. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 1997; 79:166 -72.

4. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920 -5.

5. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23:1162-70.

6. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994; 90:844 -53.

7. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16:523-32.

8. Mohler ER III, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999; 8:254-60.

9. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low-density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19:1218 -22.

10. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73-92.

11. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves.Circulation 2001; 103:1522- 8.

12. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001; 10:371- 4.

13. O’Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensinconverting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002; 106:2224-30.

14. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in nonrheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002; 88:348 -51.

15. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003; 107:2181-4.

16. Sasayama S, Ross J Jr, Franklin D, Bloor CM, Bishop S, Dilley RB. Adaptations of the left ventricle to chronic pressure overload. Circ Res 1976; 38:172- 8.

17. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43:1189 -94.

18. Spann JF, Bove AA, Natarajan G, Kreulen T. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. Circulation 1980; 62:576-82.

19. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988; 9 Suppl E: 19-23.

20. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976; 18:255- 64.

21. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59:679-88.

22 Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis.Circulation 1981; 64:126-34.

23 Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation 1980; 62:42- 8.

24. Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 1976; 38:645-53.

25. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984; 69:55-65.

26. Murakami T, Hess OM, Gage JE, Grimm J, Krayenbuehl HP.Diastolic filling dynamics in patients with aortic stenosis. Circulation1986; 73:1162-74.

27. Stott DK, Marpole DG, Bristow JD, Kloster FE, Griswold HE.The role of left atrial transport in aortic and mitral stenosis.Circulation 1970;41:1031- 41.

28. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronicleft ventricular hypertrophy. Circ Res 1981; 48:76-87.

29. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris inpatients with aortic stenosis and normal coronary arteries. N EnglJ Med 1982; 307:1362- 6.

30. Carabello BA. Clinical practice: aortic stenosis. N Engl J Med2002; 346:677- 82.

32. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:226270.

33. Cheitlin MD, Gertz EW, Brundage BH, Carlson CJ, Quash JA,Bode RS Jr. Rate of progression of severity of valvular aortic stenosisin the adult. Am Heart J 1979; 98:689 -700.

34. Wagner S, Selzer A. Patterns of progression of aortic stenosis: alongitudinal hemodynamic study. Circulation 1982; 65:709 -12.

35. Jonasson R, Jonsson B, Nordlander R, Orinius E, Szamosi A. Rateof progression of severity of valvular aortic stenosis. Acta Med Scand1983; 213:51- 4.

36. Nestico PF, DePace NL, Kimbiris D, et al. Progression of isolatedaortic stenosis: analysis of 29 patients having more than 1 cardiaccatheterization. Am J Cardiol 1983; 52:1054-8.

37. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progressionof aortic stenosis in adults assessed by Doppler echocardiography.J Am Coll Cardiol 1989;13:545-50.

38. Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB.Progression of aortic stenosis in adults: new appraisal using Dopplerechocardiography. Am Heart J 1990; 119:331- 8.

39. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 1991; 12:10-4.

40. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression ofvalvular aortic stenosis in adults. Am J Cardiol 1992; 70:229 -33.

41. Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D.Progression of aortic stenosis: role of age and concomitant coronaryartery disease. Chest 1993; 103:1715-9.

42. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aorticstenosis in 394 patients: relation to changes in myocardial and mitralvalve dysfunction. J Am Coll Cardiol 1995; 25:30543. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109:2302-2308.

43. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109:2302–2308

44. Vaturi M, Porter A, Adler Y, et al. The natural history of aortic valve disease after mitral valve surgery. J Am Coll Cardiol 1999; 33:2003-8.

45. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J. 2004; 25:199 -205.

46. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38:61-7.

47. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival.Circulation 1982; 66:1105-10.

48 Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease.Eur Heart J 1987; 8:471- 83.

49. Horstkotte D, Loogen F. The natural history of aortic valvestenosis. Eur Heart J 1988;9 Suppl E:57-64.

50. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML,Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis.Am J Cardiol 1988; 61:123-30.

51. Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J1995; 74:481- 4.

52. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M.Natural history of aortic valve stenosis of varying severity in theelderly. Am J Cardiol 1996; 78:97- 01.

53. Frank S, Johnson A, Ross J Jr. Natural history of valvular aorticstenosis. Br Heart J 1973; 35:416.

54. Chizner MA, Pearle DL, deLeon AC Jr. The natural history ofaortic stenosis in adults.Am Heart J 1980; 99:419 -24.

55. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The naturalhistory of adults with asymptomatic, hemodynamically significantaortic stenosis. J Am Coll Cardiol 1990; 15:1012-7.

56. Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Natural history of moderate aortic stenosis. J Am Coll Cardiol 1991; 17:313-9.

57. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111:3290 -5.

58. Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M,Otto CM. Physical examination in valvular aortic stenosis: correlationwith stenosis severity and prediction of clinical outcome. AmHeart J 1999; 137:298 -306.

59. Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise etesting. Heart 2001; 86:381- 6.

60. Das P, Rimington H, Chambers J. Exercise testing to stratify risk inaortic stenosis. Eur Heart J 2005; 26:1309 -13.

61. Nylander E, Ekman I, Marklund T, Sinnerstad B, Karlsson E,Wranne B. Severe aortic stenosis in elderly patients. Br Heart J1986; 55:480 -7.

62. Atwood JE, Kawanishi S, Myers J, Froelicher VF. Exercise testingin patients with aortic stenosis. Chest 1988; 93:1083-7.

63. Clyne CA, Arrighi JA, Maron BJ, Dilsizian V, Bonow RO, CannonRO III. Systemic and left ventricular responses to exercise stress inasymptomatic patients with valvular aortic stenosis. Am J Cardiol1991; 68:1469 -76.

64. Otto CM, Pearlman AS, Kraft CD, Miyake-Hull CY, Burwash IG,Gardner CJ. Physiologic changes with maximal exercise in asymptomaticvalvular aortic stenosis assessed by Doppler echocardiography.J Am Coll Cardiol 1992; 20:1160 -7.

65. Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomaticpatients with valvular aortic stenosis. J Heart Valve Dis 2002; 11:204-9.

66. Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-termoutcome: a multicenter study using dobutamine stress hemodynamics.Circulation 2003; 108:319 -24.

67. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am J Cardiol 1984; 53:194 -7.

68. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B.Percutaneous transluminal valvuloplasty of acquired aortic stenosisin elderly patients: an alternative to valve replacement? Lancet1986; 1:63-7.